The Stanley J. Korsmeyer Award
The Stanley J. Korsmeyer Award is named in honor of Dr. Korsmeyer,
who was the first recipient of the Award in 1998 and who passed away in March 2005.
The annual Award recognizes the outstanding achievements of ASCI members in
advancing knowledge in a specific field and in mentoring future generations of
life science researchers. The Award recipient receives an unrestricted $20,000
grant from the Society and presents the Award Lecture at the Society’s
Nominations for the 2017 Award
Nominees for the Stanley J. Korsmeyer Award must be ASCI members who are 55 years of age or younger as of January 1, 2017. They shall have made significant contributions to biomedical science and shall have adhered to the principles of scientific excellence that the ASCI exemplifies. The nominee should have a record that reflects high standards of intellectual integrity, a deep and abiding respect for the community of biomedical scientists, and a strong commitment to mentoring the next generation of physician-scientists. Prior nominees may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.
Nominations consist of:
- a summary of the nominee’s accomplishments (in plain text, not to exceed 250 words),
- a brief NIH biosketch (as a PDF),
- and a trainee table (preferred as a PDF).
Nominations must be submitted by ASCI members through their online accounts.
The deadline for nominations is October 24, 2016, at 11:59 PM EDT.
Jean-Laurent Casanova, MD, PhD, is the recipient of the 2016 American Society for Clinical Investigation (ASCI) Stanley J. Korsmeyer Award in recognition for his discovery that single-gene inborn errors of immunity can underlie life-threatening infectious diseases in otherwise healthy children and young adults.
Past award recipients
2015: Louis J. Ptáček
For research leading to the development of the field of ion channel defects, known commonly as channelopathies. More information
2014: Beth Levine
In recognition of fundamental contributions to our understanding of autophagy. More information
2013: Bruce Beutler
In recognition of his contributions to the field of innate immunity. More information
2012: William G. Kaelin, Jr., and Gregg L. Semenza
In recognition of their contributions to the molecular understanding of cellular oxygen sensing and cellular adaptation to hypoxia. More information
2011: Brian J. Druker and Charles L. Sawyers
In recognition of their contributions to the development of novel therapeutics in the treatment of leukemia and other forms of cancer. More information
2010: Andrew R. Marks
In recognition of his discoveries that rapamycin inhibits coronary artery stent restenosis, and the role of leaky ryanodine receptor/calcium release channels in heart failure, cardiac arrhythmias and muscular dystrophy. More information
2009: Mitchell A. Lazar
For his outstanding contributions to our understanding of the transcriptional regulation of metabolism. More information
2008: Gerald I. Shulman
For his contributions to furthering our understanding of the mechanisms underlying the pathogenesis of type 2 diabetes. More information
2007: D. Gary Gilliland
For his contributions to the understanding of the genetic basis of human hematological malignancies. More information
2006: Shaun R. Coughlin
For his outstanding contributions in the field of signal transduction via thrombin receptors. More information
2005: Francis Collins
For his pioneering efforts in the development of the entire field of human genome research. More information
2004: David Ginsburg
For his contributions to the understanding of the molecular basis of physiologic and pathologic thrombosis and hemostasis. More information
2003: Craig B. Thompson
For his discovery of the critical role costimulatory receptors play in regulating immune responses. More information
2002: Ronald DePinho
For fundamental discoveries in cancer research, aging, and chronic degenerative disease. More information
2001: Laurie Glimcher
For seminal contributions to our understanding of the transcriptional regulation of lymphocyte subset differentiation.
2000: Christine Seidman
For employing molecular genetic approaches in defining the etiology of inherited human disorders and genetic engineering to produce murine models of human disease, with particular emphasis on heart disease.
Finalists: Jonathan S. Stamler, for elucidating the fundamental role of redox systems in the control of complex physiological responses, using NO-based modification of proteins-in particular S-nitrosylation. Mark Keating, for focusing on the molecular genetics of cardiovascular disease, particularly cardiac arrhythmias, cardiomyopathy and obstructive vascular disease.
1999: Richard D. Klausner
For the discovery of key mechanisms that regulate metal metabolism and intracellular trafficking. More information
Finalists: Michael J. Welsh, for discoveries regarding the molecular and cellular pathogenesis of cystic fibrosis. David Clapham, for discoveries regarding the regulation of membrane ion channels, and the physiologic consequences of intracellular calcium signals.
1998: Stanley J. Korsmeyer
For the identification of key genetic mechanisms that govern cell death and survival. More information
Finalists: Peter Agre, for discoveries regarding the roles of water channels in cell membranes. Arthur Weiss, for discoveries of key signalling pathways in T lymphocytes.